AB
NVAX icon

Amalgamated Bank’s Novavax NVAX Stock Holding History

Amalgamated Bank’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,704
Closed -$32K – 2427
2025
Q4 		$32K Sell
4,704
-634
-12% -$4.78K ﹤0.01% 1953
2025
Q3 		$46K Hold
5,338
– – ﹤0.01% 1865
2025
Q2 		$34K Hold
5,338
– – ﹤0.01% 1940
2025
Q1 		$34K Buy
5,338
+451
+9% +$3.73K ﹤0.01% 1895
2024
Q4 		$39K Hold
4,887
– – ﹤0.01% 1896
2024
Q3 		$62K Hold
4,887
– – ﹤0.01% 1788
2024
Q2 		$62K Buy
4,887
+1,036
+27% +$10.4K ﹤0.01% 1812
2024
Q1 		$18K Sell
3,851
-7,430
-66% -$34.5K ﹤0.01% 2172
2023
Q4 		$54K Sell
11,281
-819
-7% -$5.01K ﹤0.01% 2209
2023
Q3 		$88K Hold
12,100
– – ﹤0.01% 2044
2023
Q2 		$90K Sell
12,100
-5,193
-30% -$40.8K ﹤0.01% 2100
2023
Q1 		$120K Sell
17,293
-350
-2% -$3.22K ﹤0.01% 1980
2022
Q4 		$181K Hold
17,643
– – ﹤0.01% 1897
2022
Q3 		$321K Buy
17,643
+200
+1% +$8.67K ﹤0.01% 1633
2022
Q2 		$897K Sell
17,443
-103
-0.6% -$5.33K 0.01% 1190
2022
Q1 		$1.29M Buy
17,546
+1,566
+10% +$140K 0.01% 1105
2021
Q4 		$2.29M Buy
15,980
+1,459
+10% +$251K 0.02% 878
2021
Q3 		$3.01M Sell
14,521
-816
-5% -$180K 0.03% 755
2021
Q2 		$3.26M Buy
15,337
+9,340
+156% +$1.71M 0.03% 749
2021
Q1 		$1.09M Sell
5,997
-500
-8% -$99.6K 0.04% 500
2020
Q4 		$724K Buy
6,497
+23
+0.4% +$2.44K 0.03% 752
2020
Q3 		$701K Buy
6,474
+283
+5% +$34.5K 0.03% 651
2020
Q2 		$516K Buy
+6,191
New +$237K 0.02% 814
2019
Q2 		– Sell
-2,816
Closed -$31K – 1806
2019
Q1 		$31K Buy
2,816
+98
+4% +$3.09K ﹤0.01% 1670
2018
Q4 		$100K Buy
2,718
+658
+32% +$25.5K ﹤0.01% 1524
2018
Q3 		$77K Sell
2,060
-675
-25% -$19K ﹤0.01% 1401
2018
Q2 		$73K Buy
2,735
+654
+31% +$22.1K ﹤0.01% 1674
2018
Q1 		$87K Sell
2,081
-50
-2% -$2.01K ﹤0.01% 1542
2017
Q4 		$53K Buy
2,131
+379
+22% +$9.25K ﹤0.01% 1608
2017
Q3 		$40K Sell
1,752
-25
-1% -$560 ﹤0.01% 1561
2017
Q2 		$41K Buy
1,777
+121
+7% +$2.37K ﹤0.01% 1551
2017
Q1 		$42K Hold
1,656
– – ﹤0.01% 1478
2016
Q4 		$42K Buy
1,656
+223
+16% +$6.5K ﹤0.01% 1491
2016
Q3 		$60K Buy
1,433
+7
+0.5% +$904 ﹤0.01% 1357
2016
Q2 		$196K Buy
1,426
+15
+1% +$1.72K 0.01% 1271
2016
Q1 		$146K Buy
1,411
+123
+10% +$13.2K 0.01% 1196
2015
Q4 		$216K Sell
1,288
-122
-9% -$18.8K 0.03% 1015
2015
Q3 		$199K Buy
1,410
+23
+2% +$5.16K 0.02% 1156
2015
Q2 		$309K Buy
1,387
+196
+16% +$34.5K 0.03% 949
2015
Q1 		$197K Buy
1,191
+47
+4% +$7.63K 0.02% 883
2014
Q4 		$136K Buy
1,144
+3
+0.3% +$314 0.02% 823
2014
Q3 		$95K Buy
1,141
+120
+12% +$10.8K 0.01% 818
2014
Q2 		$94K Buy
1,021
+60
+6% +$5.27K 0.01% 849
2014
Q1 		$87K Sell
961
-1
-0.1% -$112 0.02% 802
2013
Q4 		$98K Buy
+962
New +$68K 0.02% 804

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Bank's NVAX Position: Q1 2026 in Review

Amalgamated Bank sold out of Novavax (NVAX) in Q1 2026, closing a stake of 4,704 shares — an estimated $32K sold.

Amalgamated Bank first reported a position in NVAX in Q4 2013 and held it in 45 quarters. The position peaked at $3.26M in Q2 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Amalgamated Bank reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 4,704 Novavax shares in Q1 2026, an estimated $32K.
  • Amalgamated Bank first reported a position in Novavax in Q4 2013 and held it in 45 quarters.
  • Amalgamated Bank's Novavax position peaked at $3.26M in Q2 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.